morphism or whether the pattern is itself influenced by the nature of the viral target antigen. The present report describes experiments in which EB virusspecific cytotoxic T cells, prepared from HLA-A2-positive donors and expanded in vitro to give interleukin 2 (IL-2)-dependent T cell lines, have been tested on a large panel of target cell lines of known HLA type. The results on the one hand show that serologically indistinguishable HLA-A2 antigens can indeed bear different T cell-restricting determinants, while on the other hand provide one instance in which a serologically defined cross-reaction between otherwise quite distinct antigens, HLA-A2 and HLA-Bw57, appears to be reflected in a corresponding cross-reactivity of cytotoxic T cell-restricting determinants.
Materials and Methods
Blood Donors. 60-ml blood samples were taken from healthy adult donors by venipuncture into sterile heparinised (10 U/ml) syringes, and peripheral blood mononuclear (PBM) cells were separated by centrifugation on Ficoli-Hypaque. The donors' immune status with respect to EB virus was assessed by measuring serum antibodies to the EB viral capsid antigen (17) .
Cell Lines. EB virus-transformed lymphoblastoid cell lines were prepared from blood donors by experimental infection of T lymphocyte-depleted PBM cells (18) . The lymphoblastoid cell line from donor M7 was kindly provided by Dr. W. E. Biddison, National Institutes of Health, Bethesda, MD. In addition, certain experiments included the EB virus genome-negative human leukemic cell lines HSB2 and K562, known to be very sensitive to natural killer-like cytotoxicity (19) . All the cell lines were maintained by twiceweekly subculture in RPMI 1640 medium supplemented with 2 mM glutamine, 100 U/ ml penicillin, 100 #g/ml streptomycin, and 10% fetal calf serum ("culture medium").
HLA-typing.
Typing of donors for HLA-A, -B, and -C, and HLA-DR antigens was carried out on PBM cells and on T-depleted PBM cells, respectively; with certain donors the typing was confirmed on the corresponding EB virus-transformed cell line. Preparation of EB Virus-specific Effector T Cells. EB virus-specific cytotoxic T cell precursors, present in the blood of immune donors, were reactivated in vitro using a modified version of published methods (24, 25) . Briefly, 2 X 106 PBM cells were cultured with 5 x 104 x-irradiated (4,000 rad) stimulator cells of the autologous EB virus-transformed cell line in 2-ml flat-bottomed wells (Linbro Chemical Co., Hamden, CT). After 10 d incubation at 37°C, in an atmosphere of 5% CO~ in air, the cultures were harvested and the T cell fraction prepared by E-rosetting with sheep erythrocytes treated with 2-aminoethyli-sothiouronium bromide hydrobromide. A second in vitro stimulation was then carried out by culturing 5 × 105 T cells with 2 x 105 x-irradiated stimulator cells in 2-ml wells for a further 4-6 d, after which 5 x 105 of the viable cells from these cultures were reseeded with 2 x 10 s x-irradiated stimulator cells in the presence of culture supernatants that contained IL-2 prepared as described elsewhere (25) . Cytotoxic T cell lines established in this way could be maintained for many weeks by regular reseeding in IL-2 medium (twice weekly) with weekly additions of x-irradiated stimulator cells.
Cytotoxicity Assays. Effector T cells from the IL-2-dependent T cell lines were washed and resuspended in fresh IL-2-free medium for 12-18 h before assay. Target cells and where necessary unlabelled "cold targets," were taken from the panel of cell lines described above; on certain occasions, target cells included mitogen-stimulated lymphoblasts prepared from cultures of PBM cells either 3 d after exposure to phytohemagglutinin (PHA) or 5 d after exposure to pokeweed mitogen (PWM). The conduct of the 5-h chromiumrelease assay, and of cold target competition experiments was exactly as described elsewhere (26) , except that the majority of assays were conducted over a range of different effector/target ratios (2 
Analysis of Results of Cytotoxicity Assays. To allow comparison of results from repeated
testing of the same effector/target cell combination, the specific lysis was expressed on each occasion as a percentage of the autologous target cell lysis observed in the same experiment at the same effector/target ratio. The mean and standard deviation of the relative percentage lysis were then calculated for each effector/target combination. In the present experiments, the absolute level of autologous target cell iysis seen in the 5-h chromium-release assay was usually between 35 and 55% at an effector/target ratio of 5:1.
Experimental Procedure. EB virus-specific cytotoxic T cell lines were established from nine virus-immune donors positive for the serologically defined HLA-A2 antigen, and the identity of the dominant class I HLA-restricting determinants was revealed by testing on a suitable panel of HLA-typed lymphoblastoid cell lines. Effector T cells lines that possessed demonstrable A2-restricted cytotoxicity (from four of the original nine donors) were selected for further study. Each was tested against a common panel of 20 EB virustransformed HLA-A2-positive target cell lines, including in each case the autologous line as well as a majority of the available lines matched with the effector cells through HLA-A2 alone. Matching through HLA-C and -DR antigens was not considered since these molecules do not serve as major restricting determinants of EB virus-specific cytotoxicity (12, 26) .
In further experiments, lysis of autologous and of HLA-A2-matched target cells by all four populations of effector cells was tested in the presence and absence of high concentrations of the monoclonal antibodies MA2.1 and W6/32. The specificity of one population of effector cells was further examined by testing on both EB virus-transformed and mitogen-stimulated target cells from the same individuals, as well as in cold target competition experiments. deviation as shown. The figure shows only a representative range of the target cell lines actually tested. Although the autologous line was always perferentially killed, lysis of allogeneic EB virus-transformed lines could clearly be mediated through HLA-A2 antigen matching and to a lesser extent through Bw44 antigen matching. In contrast, target cells lines bearing only B40 in common with the effector cells were not killed above the low background level shown by HLAmismatched lines. This is a reflection of a more general phenomenon seen in this system whereby effector cell preparations from individual donors consistently show preferential restriction through particular HLA-A or -B antigens (26) . Thus, of nine HLA-A2 EB virus-immune donors tested in the course of this work (five of whom are A2 homozygous), only four (three of whom are A2 homozygotes) generated cytotoxic T cell lines containing a demonstrable A2-restricted component. Table I gives the HLA types of these four donors and indicates in each case the HLA antigens which were dominant restriction elements (as determined from tests upon a panel of 30-50 allogeneic virus-transformed cell lines of known HLA type). It is noteworthy that these effector T cell preparations, like those described in earlier work (26) , did not kill the EB virus-genuine-negative leukemic cell lines HSB2 and K562, which were included as sensitive indicators of nonspecific natural killer-like activity (data not shown). It is clear that 16 of 20 HLA-A2 target cell lines were consistently lysed by all four effector populations at levels above 25% of autologous cell lysis. In contrast, there was no significant killing of three particular lines (AMc, AD, M7) by any of the effector cell populations, nor of one line (RT) by three of the four effector T cell lines. The discordant results obtained with these target cell lines were consistent in repeated testing of each of the effector cell populations and were confirmed when new cytotoxic T cell preparations were made from fresh blood samples from two available donors (KG, DG).
Results

HLA-restricted Nature of EB Virus-spec~c Cytotoxic T Cell Lines.
Failure of HLA-A2-restricted Cytotoxic T Cells to
The distinctions between different cell lines within the target cell panel apparent from Fig. 2 were clearly seen across a range of effector/target cell ratios as exemplified by the results of Fig. 3 . Increasing numbers of effector cells from donor BW showed increasingly strong lysis of five HLA-A2-matched target cell lines from the main panel, while lysis of the AMc, RT, and M7 cell lines remained at the very low level shown with an HLA-mismatched control target. Such results did not reflect an insensitivity of these particular cell lines to lysis by all EB virus-specific effector cells, since in parallel tests each of these lines has been reproducibly killed by virus~specific effector cell populations restricted through antigens other than HLA-A2. Thus RT cells are sensitive to A3-and B7-restricted effectors and M7 cells are sensitive to Bw35-restricted effectors (data not shown).
Blocking of HLa-A2-restricted Lysis by an A2-spec~c monoclonal Antibody. Fig. 4 shows representative data from further experiments in which high tiler preparations of the monoclonal antibodies MA2.1 (anti-HLA-A2) and W6/32 (anti-A, -B, -C common antigen) were tested for their effect upon target cell lysis. These particular results were obtained using effector cells from donor DG but illustrate a pattern that was observed for all four effector cell preparations. Thus MA2.1 had only a marginal effect upon autologous target cell lysis when compared with the marked reduction of this lysis seen in the presence of W6/ 32. However, where the effector and target cells were matched only through HLA-A2 (targets EL and AH), MA2.1 blocked lysis as effectively, as did W6/ 32. Moreover the HLA-A2-specific monocional antibody had no effect on the HLA-B8-restricted cytotoxicity present within this same effector population (target LGYS). It was interesting to note that the low level of killing of the anomalous HLA-A2-positive target cell line M7 was also unaffected by MA2.1. shown by the other three effector cell populations except that EL effector cells showed consistent lysis of the otherwise anomalous RT cell line (Fig. 2) . It was therefore most important to determine whether this did indeed represent virusspecific HLA-A2-restricted killing. In this regard, it was found that lysis of RT cells by EL effector cells was very sensitive to the blocking effect of the monoclonal antibody MA2.1 (>80% reduction); lysis of other HLA-A2-positive targets such as DG cells by the same effector cells was less sensitive to blocking (30-40% reduction) in these particular tests. Lysis of both RT and DG cells proved equally sensitive to blocking by W6/32 (30-40% reduction) in these same tests.
Cross-reactive L ysis of HLA-Bw5 7-positive EB Virus-transformed Cells by E ffector
This result raised the possibility that lysis of RT cells was mediated through a polymorphic HLA determinant closely associated with the MA2.1 binding site and present on the HLA-A2,A3,B7,Bw57-positive RT cell line. The fact that MA2.1 binds not only to HLA-A2 antigens but also to a cross-reactive epitope on HLA-Bw57 antigens (21) prompted a final series of experiments in which the testing of EL effector cells was extended to include HLA-A2-negative, Bw57-positive target cell lines.
The results, presented in Fig. 5A , clearly show the existence of a cross-reaction against Bw57-positive cell lines LM and TH, which, though not quite as strong as the well-documented reaction against A2-positive lines such as DG and KG, was nevertheless significant and reproducible. In contrast, mitogen-stimulated lymphoblasts from donors RT and LM (Fig. 5A) as well as from other Bw57-positive donors (data not shown) did not suffer significant lysis when included as targets in the same assays. Finally, in cold target competition experiments designed to identify the dominant antigen restricting the EL/RT effector/target interaction, lysis of the RT cell line was inhibited very efficiently by the A2-negative, Bw57-positive TH cell line, whereas the A2-positive, Bw57-negative DG and KG cell lines competed only marginally better than two negative controls (Fig. 5B) . Furthermore, the HLA-A2-restricted lysis of the KG cell line by EL effector cells could be inhibited by another HLA-A2-positive cell line (JM) from the main HLA-A2 panel, while the RT cell line itself proved to be a relatively poor competitor (Fig. 5 C) .
Discussion
The evidence is now very strong that class I HLA antigens on the surface of target cells bear the polymorphic restricting determinants that govern virusspecific cytotoxic T cell function in man (4-10, 27). 2 However, it is not yet clear how closely the serologically defined polymorphisms of HLA antigen structure reflect the heterogeneity of T cell-restricting determinants or how this heterogeneity might itself be influenced by the identity of the viral antigen against which the cellular response is directed. The present work describes experiments in the EB virus system that bear principally upon the first question but which could in the longer term contribute towards resolution of the second. The present study was made possible through the development of methods whereby EB virus-specific cytotoxic T cells, reactivated in vitro from memory cells in the circulation of virus-immune individuals (18), could be expanded as IL-2-dependent effector cell lines (25) . These lines displayed a virus-specific, HLA-restricted cytotoxicity in which the pattern of restriction of the original effector cell population (often involving preferential recognition through just one or two of the available HLA-A and -B antigens) was faithfully maintained. The present studies focused on cytoxicity through HLA-A2, since experiments with influenza virus-specific cytotoxic T cells had already suggested the existence of heterogeneity within this serologically defined antigen (14) (15) (16) 28) . Out of nine HLA-A2-positive EB virus-immune donors from whom effector cell lines were established, only four (including three A2 homozygotes) generated a demonstrable A2-restricted component within the polyclonal, cytotoxic response (Table I) . Since the five donors with no detectable A2-1inked response were all .
subsequently shown (through testing of their virus-transformed cells as targets) to bear the "common A2" antigen and not some unusual variant, the results in these cases are consistent with our earlier observations (26) suggesting that A2 is not usually a preferred antigen for the restriction of EB virus-specific cytolysis.
Testing of four separate HLA-A2-restricted effector cell populations on the same panel of 20 HLA-A2-positive EB virus-transformed target cell lines clearly identified a group of four lines (RT, AMc, AD, M7) whose lysis was generally very low. When the cells of these particular lines were serologically typed, their HLA antigen expression was in accord with that expected from the HLA type of the original donor and included expression of the serologically defined HLA-A2 molecule. Moreover, the four lines, as well as a representative number of lines tested from within the main panel of target cells, all bound the HLA-A2/ B17-specific monoclonal antibody MA2.1 and the monoclonal antibody FMC5, whose reactivity, though less well defined, is also against an HLA-A2-associated determinant. The discordant results obtained with the RT, AMc, AD, and M7 target cell lines in the cytotoxicity assays in Figs. 2 and 3 did not reflect an insusceptibility to EB virus-specific cytolysis per se since each line could be killed by virus-specific effector cells restricted through other class I HLA antigens on the target cell surface. The A2-restricted nature of the killing of those target cell lines within the main body of the panel was confirmed, in that lysis could be specifically blocked by high concentrations of the MA2.1 monoclonal antibody. In these same tests, the much lower level of killing directed against the anomalous target cell lines was not at all affected by MA2.1, suggesting that none of this residual lysis was actually HLA-A2 restricted.
The inference from these results must be that EB virus-specific cytolysis was being mediated through a polymorphic determinant (or determinants) common to most, but not all, serologically defined HLA-A2 molecules. It was interesting to note that, even within the panel of common-A2-bearing targets, each effector cell population produced its own characteristic pattern of lysis, with stronger reactivity against some targets than others. This is somewhat reminiscent of results recently obtained from an analysis of HLA-A3-restricted T cell cytolysis in the influenza virus system (29) that led those workers to suggest the existence of multiple restriction sites on the A3 molecule. A similar inference might also be drawn for the common A2 molecule from the present work, but positive proof of this thesis requires evidence from A2-restricted T cell clones, each specific for a single restriction site.
It will be important to determine whether the four target cell lines RT, AMc, AD, and M7, seroiogically typed as HLA-A2-bearing but lacking the common-A2-associated restricting determinant(s), all possess the same variant A2 molecule or whether each is itself distinct; the latter suggestion may be more likely because donors RT and AMc are Caucasian in origin, while M7 and AD are Black and Asian, respectively.
In this context, the consistent lysis of RT target cells by effector cells from donor EL was particularly interesting, especially as EL is homozygous for HLA-A2 (serologically defined) and might conceivably possess T cells restricted through a "variant A2"-associated determinant in addition to the common-A2-associated reactivity dominating the other three effector cell preparations tested in this work. In fact, further analysis of the effector EL/target RT interaction did not substantiate this possibility but instead revealed the existence within the EL effector cell population of an unexpected cross-reactivity directed against HLA-Bw57-bearing target cell lines (Fig. 5) .
This was not a cross-reactivity against an allo-determinant per se, of the kind that has been detected in various antigen-specific murine cytotoxic T cell systems (30) (31) (32) , since only EB virus-transformed and not mitogen-stimulated (PHA or PWM) Bw57-bearing lymphoblasts were recognized. Thus it appeared to reflect a cross-reactivity at the level of HLA-restricting determinants that mediated EB virus-specific cytolysis. In relation to this, it is important to note that HLA-A2 (the dominant restricting element for EL effector cell preparations) and HLABw57 (the source of cross-reactivity) are already known to share common epitopes as defined by the monoclonal antibody MA2.1 (21) and by certain conventional HLA typing sera (33) . The fact that MA2.1 blocked the effector EL/target RT interaction with such unusual efficiency adds weight to the view that lysis here is being mediated through a restricting determinant common to HLA-A2 and Bw57 molecules. If this is the case, clearly only a minority of the A2-restricted clones within the EL effector cell population recognize this particular determinant, since lines bearing the common A2 antigen such as DG or KG proved relatively poor competitors of RT cell lysis in comparison with HLA-Bw57-bearing competitor cell lines (Fig. 5B) . Although the point is by no means proven, these findings do highlight the possibility that known, serologically defined cross-reactions between otherwise distinct HLA antigens might in some cases identify common epitopes capable of restricting T cell function. The possibility is one that must now be pursued by T cell cloning.
Finally, the present work must be viewed in the context of parallel studies in the influenza virus-specific (14) (15) (16) 28) , H-Y antigen-specific (34, 35) , and allospecific (36, 37) human cytotoxic T cell systems, each of which also provides evidence of HLA-A2 heterogeneity. It will be important to compare the subdivisions of HLA-A2 that these different cellular probes reveal. The limited evidence available to date on this point is interesting in that, of the donors with variant A2 expression identified in this present study using EB virus-specific effectors, both M7 (14, 15, 34) and AMc (28, 35 ; referred to as AM) have also been detected as A2 variants using influenza virus-specific and H-Y antigenspecific cytotoxic T cells. It remains to be seen whether this pattern of agreement is maintained with more extensive analysis and indeed whether heterogeneity of HLA-A2 as defined by cellular probes is always reflected in altered biochemical properties of the A2 molecule (16) . Whatever the answers to these questions, the work on HLA-A2 antigen heterogeneity has clearly established an experimental basis for the more general analysis ofpolymorphism amongst MHC gene product in man. Summary Epstein-Barr (EB) virus-specific effector T cell lines were established from nine virus-immune donors positive for the serologically defined HLA-A2 antigen; of these, four lines contained a demonstrable A2-restricted cytotoxic component. When these four effector populations were each tested on the same panel of EB virus-transformed lines from 20 HLA-A2-positive individuals, 16 of the target cell lines were consistently killed at levels above 25% of the relevant autologous cell iysis. Cytotoxicity appeared to be mediated through a restricting determinant associated with the 'common A2' antigen that these lines shared; indeed the lysis could be specifically blocked by high concentrations of an HLA-A2-specific monoclonal antibody. In contrast, 4 out of 20 target cell lines were not killed by HLA-A2-restricted effector cells, even though they did express the serologically defined A2 antigen and were found in other tests to be susceptible to EB virusspecific cytolysis restricted through other HLA-A or -B antigens on their surface.
These results suggest that EB virus-specific cytotoxic T cells can distinguish between serologically identical HLA-A2 molecules via the heterogeneity of their T ceil-restricting determinants. Data from one of the effector cell populations further suggested that a serologically defined cross-reaction between the otherwise distinct HLA-A2 and -Bw57 antigens might also be reflected in a crossreactivity of T cell-restricting determinants.
